[Case of very severe allergic reaction in peroral management of diabetes mellitus with a sulfonyl urea derivative, N1-sulfanilyl-N2-n-butylcarbamide].
D002271:Carbutamide; D003920:Diabetes Mellitus / Q000628:therapy*; D019468:Disease Management; D006967:Hypersensitivity; D000077145:Sulfanilamide; D013424:Sulfanilamides / Q000031:analogs & derivatives; D014508:Urea / Q000031:analogs & derivatives
D013424:Sulfanilamides; D000077145:Sulfanilamide; D014508:Urea; D002271:Carbutamide
ALLERGY; DIABETES MELLITUS/therapy; SULFANILAMIDE/related compounds; UREA/related compounds
Uber einen Fall von schwerster allergischer Reaktion bei der peroralen Behandlung des Diabetes mellitus mit einem Sulfonylharnstoffderivat (N1-sulfanilyl-N2-n-butylcarbamid).